| Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors (NCT06639256) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-10-24 |
| Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects (NCT07364669) | Laboratorios Pisa S.A. de C.V. | 2024-10-24 |
| A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) (NCT06649110) | Novartis Pharmaceuticals | 2024-10-24 |
| A Study of DM001 in Patients With Advanced Solid Tumors (NCT06475937) | Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | 2024-10-24 |
| Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer (NCT06667960) | Salubris Biotherapeutics Inc | 2024-10-23 |
| A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i) (NCT06343805) | Ajax Therapeutics, Inc. | 2024-10-23 |
| A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder (NCT06618118) | AbbVie | 2024-10-23 |
| A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers (NCT06636877) | Boryung Pharmaceutical Co., Ltd | 2024-10-23 |
| A Study of Single Dose of LP-003 in Healthy Adult Subjects (NCT06604949) | Longbio Pharma | 2024-10-23 |
| A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) (NCT06644118) | Zhejiang University | 2024-10-23 |
| Diazoxide Suppression Test P&F Study (NCT06606327) | Columbia University | 2024-10-23 |
| Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors (NCT06571422) | Shanghai Junshi Bioscience Co., Ltd. | 2024-10-23 |
| PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy (NCT06522932) | Michael Randall | 2024-10-23 |
| A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults (NCT06493461) | 35Pharma Inc | 2024-10-23 |
| FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations (NCT06669117) | Pierre Fabre Medicament | 2024-10-22 |
| Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer (NCT06631521) | AdventHealth | 2024-10-22 |
| A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations (NCT06631417) | Boehringer Ingelheim | 2024-10-22 |
| Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia. (NCT06356922) | Nantes University Hospital | 2024-10-22 |
| Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) (NCT06329570) | NaviFUS Corporation | 2024-10-22 |
| MVX-ONCO-2 in Advanced Solid Tumors (NCT05071846) | University Hospital, Geneva | 2024-10-22 |
| Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance (NCT06633757) | ReCode Therapeutics | 2024-10-22 |
| A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma (NCT06716853) | Genenta Science | 2024-10-22 |
| A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL) (NCT06660563) | Janssen Research & Development, LLC | 2024-10-22 |
| Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L (NCT06539429) | Anterogen Co., Ltd. | 2024-10-22 |
| A Study of LY4065967 in Healthy Japanese Participants (NCT06594159) | Eli Lilly and Company | 2024-10-22 |
| BnH-015B Clinical Trial in Moderate Alzheimer's Disease (NCT06535308) | BnH Research | 2024-10-22 |
| First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants (NCT06673667) | Kymera Therapeutics, Inc. | 2024-10-22 |
| Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety (NCT06816667) | Biomind Labs Inc. | 2024-10-21 |
| A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors (NCT06607185) | Eli Lilly and Company | 2024-10-21 |
| A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants (NCT06651021) | AstraZeneca | 2024-10-21 |
| A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033) (NCT06609512) | Merck Sharp & Dohme LLC | 2024-10-21 |
| Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease (NCT06522373) | M.D. Anderson Cancer Center | 2024-10-21 |
| Pharmacokinetic and Safety Study of Subcutaneous and Intravenous Anifrolumab Delivered in Healthy Adult Participants (NCT06662123) | AstraZeneca | 2024-10-21 |
| ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS) (NCT06430385) | Ionis Pharmaceuticals, Inc. | 2024-10-21 |
| Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic Overweight or Obese Adult Subjects (NCT06714955) | BrightGene Bio-Medical Technology Co., Ltd. | 2024-10-21 |
| Efficacy of Mazdutide for Treating PCOS (NCT06519656) | Shanghai Zhongshan Hospital | 2024-10-21 |
| Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis (NCT07612280) | Jubilant Therapeutics Inc. | 2024-10-21 |
| Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients (NCT06730009) | Medigen Biotechnology Corporation | 2024-10-21 |
| Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Conditions (NCT06762743) | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 2024-10-21 |
| A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension (NCT06554301) | China National Center for Cardiovascular Diseases | 2024-10-20 |
| A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects (NCT06597422) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2024-10-20 |
| TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas (NCT06640582) | Essen Biotech | 2024-10-20 |
| An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy (NCT06288230) | Lantu Biopharma | 2024-10-20 |
| Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors (NCT06598800) | BeOne Medicines | 2024-10-18 |
| A Study to Find Out How BIIB141 (Omaveloxolone) Moves From the Blood Into the Breastmilk of Healthy Women Who Are Breastfeeding or Pumping Milk (NCT06612879) | Biogen | 2024-10-18 |
| A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults (NCT06494527) | Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. | 2024-10-18 |
| A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation (NCT06599502) | AstraZeneca | 2024-10-18 |
| Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL (NCT06475235) | Dana-Farber Cancer Institute | 2024-10-18 |
| Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine (NCT05053321) | Yale University | 2024-10-18 |
| Open-Label Psilocybin Study in Transdiagnostic Population (NCT06442423) | Yale University | 2024-10-17 |
| A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer (NCT06340581) | AstraZeneca | 2024-10-17 |
| A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors (NCT06630247) | Exelixis | 2024-10-17 |
| A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) (NCT06559176) | Prime Medicine, Inc. | 2024-10-17 |
| HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors (NCT06515314) | Shanghai Ruiliyuan Biotechnology Co., Ltd. | 2024-10-17 |
| A Study of LY3866288 in Healthy Participants (NCT06641037) | Eli Lilly and Company | 2024-10-17 |
| Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants (NCT06648824) | Agios Pharmaceuticals, Inc. | 2024-10-17 |
| A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects (NCT06619392) | Shandong Suncadia Medicine Co., Ltd. | 2024-10-17 |
| IC14 for Treatment of Acute Decompensated Heart Failure (NCT06556810) | Implicit Bioscience | 2024-10-17 |
| Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus (NCT06585514) | Beijing GoBroad Hospital | 2024-10-17 |
| Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD) (NCT06597942) | University of California, Los Angeles | 2024-10-17 |
| Mass Balance Clinical Trial of SIM0270 (NCT06654791) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2024-10-17 |
| A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy Adults (NCT06645938) | Pfizer | 2024-10-16 |
| Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa) (NCT06663176) | Thirty Respiratory Limited | 2024-10-16 |
| A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors (NCT06612840) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-10-16 |
| CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies (NCT06326463) | St. Jude Children's Research Hospital | 2024-10-16 |
| Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State (NCT07568652) | Hanlim Pharm. Co., Ltd. | 2024-10-16 |
| A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (NCT06528093) | Boehringer Ingelheim | 2024-10-16 |
| Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder (NCT06538558) | Proniras Corporation | 2024-10-16 |
| A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects (NCT06659757) | Kither Biotech Srl | 2024-10-16 |
| StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms (NCT06662942) | Andrew T. Goldstein, MD | 2024-10-16 |
| A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants (NCT06640933) | Biogen | 2024-10-16 |
| A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma (NCT06637371) | Amgen | 2024-10-16 |
| Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease. (NCT06432764) | AstraZeneca | 2024-10-16 |
| Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT06549790) | Nerviano Medical Sciences | 2024-10-16 |
| Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy (NCT06554288) | Children's Mercy Hospital Kansas City | 2024-10-15 |
| A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV (NCT06642584) | Novo Nordisk A/S | 2024-10-15 |
| A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers (NCT06663319) | Janssen Research & Development, LLC | 2024-10-15 |
| RTX001 Autologous Engineered Macrophages for Liver Cirrhosis (NCT06823713) | Resolution Therapeutics Limited | 2024-10-15 |
| A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors (NCT06779851) | Bright Peak Therapeutics Inc | 2024-10-15 |
| Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia) (NCT06632470) | Baermed | 2024-10-15 |
| Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency (NCT07115082) | Yan Hongli | 2024-10-15 |
| A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of Oral Teslanbaicin in Patients With Radiation Proctitis (NCT06974123) | The First Affiliated Hospital of Xinxiang Medical College | 2024-10-15 |
| Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) (NCT06545682) | M.D. Anderson Cancer Center | 2024-10-15 |
| Study of IBI363 in Patients with Advanced First-line Gastric Cancer (NCT06610799) | Xiangdong Cheng | 2024-10-15 |
| Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy (NCT05989347) | Yale University | 2024-10-15 |
| Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC) (NCT06798454) | Parvus Therapeutics, Inc. | 2024-10-15 |
| A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine (NCT06642571) | Novo Nordisk A/S | 2024-10-15 |
| Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion (NCT05451251) | Université de Sherbrooke | 2024-10-15 |
| Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers (NCT06562192) | Novartis Pharmaceuticals | 2024-10-15 |
| AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment (NCT06611423) | AstraZeneca | 2024-10-15 |
| Study of ATX-01 in Participants With DM1 (NCT06300307) | ARTHEx Biotech S.L. | 2024-10-15 |
| A Study of MK-2060 in Healthy Participants (MK-2060-016) (NCT06582602) | Merck Sharp & Dohme LLC | 2024-10-15 |
| A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food (NCT06624072) | Boehringer Ingelheim | 2024-10-15 |
| A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer (NCT07135102) | Xiaorong Sun | 2024-10-14 |
| A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma (NCT06668987) | Heron Neutron Medical Corp. | 2024-10-14 |
| A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease (NCT06585449) | Alnylam Pharmaceuticals | 2024-10-14 |
| A Clinical Study of [225Ac]Ac-FAPI-XT(XT117) Injection in Patients With Advanced Solid Tumors (NCT07135128) | Xiaorong Sun | 2024-10-14 |
| A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors (NCT06533332) | EtiraRx Australia Pty Ltd | 2024-10-14 |
| A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer (NCT06736054) | Hoag Memorial Hospital Presbyterian | 2024-10-14 |
| A Phase Ib Study of GC101 in NSCLC (NCT06473961) | Shanghai Juncell Therapeutics | 2024-10-14 |